MedPath

Effect of Irvingia Gabonensis (Bush Mango)on Parameters Associated With Metabolic Syndrome

Not Applicable
Completed
Conditions
Metabolic Syndrome
Obesity
Dyslipidemia
Interventions
Dietary Supplement: IGOB131
Registration Number
NCT00645775
Lead Sponsor
Gateway Health Alliance
Brief Summary

The study investigated the use and efficacy of the seeds of African bush mango (Irvingia gabonensis)to control body weight, blood lipids and hormones in overweight and obese people.

Detailed Description

To assess the effects of seeds of Irvingia gabonensis on body weight, fasting blood glucose, plasma total and LDL cholesterol in 102 overweight and obese participants.

The study was a 10 week randomized, double blind, placebo controlled design. participants were randomly divided into 2 groups of 51 participants each. Group 1 was the placebo group, while Group 2 was the active group. Each group received 2 daily doses of 125 mg (before meals) of either placebo or Irvingia gabonensis.

Weight as well as fasting blood was taken at baseline and at 4, 8 and 10 weeks. No major detary changes or exercises were suggested during the study period.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
102
Inclusion Criteria
  • BMI>26
Exclusion Criteria
  • Diabetics Pregnant and lactating Participating in any other weight reducing program Smokers

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1IGOB131Compare active to placebo
Primary Outcome Measures
NameTimeMethod
Weight change10 weeks
Secondary Outcome Measures
NameTimeMethod
Change in blood lipids and hormone levels10 weeks

Trial Locations

Locations (1)

Laboratory of Nutrition & Nutritional Biochemistry

🇨🇲

Yaounde, Centre, Cameroon

© Copyright 2025. All Rights Reserved by MedPath